Testing SCTB14 for adults with advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SCTB14 in adults with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and may help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old
- Your cancer must be advanced (spread or not removable) and confirmed by a biopsy
- You must be able to take care of yourself (ECOG score 0 or 1)
- Your cancer must not have spread to the brain or spinal cord in a way that causes symptoms
- You must not have had certain cancer treatments (chemotherapy, immunotherapy, etc.) in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
This trial tests a new drug, SCTB14, as a first treatment for advanced non-small cell lung cancer that has a high level of PD-L1. It aims to see if the drug is safe and effective for people who haven't had other treatments for their cancer.
This trial tests a new drug called SCTB39G for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it can help shrink or control the cancer.
This trial tests two experimental drugs (SCTB41 and SCTB39G), given with or without standard cancer therapies, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and effective.
This trial tests a combination of two cell-based therapies (SCTB41 and SCTB39-1) with or without standard cancer treatments for advanced solid tumors. The goal is to see if this approach helps slow or shrink tumors while being safe enough to use in patients.
Hear when a new Advanced Malignant Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.